mRNA vaccines developed against the spike glycoprotein of severe acute respiratory syndrome type 2 coronavirus (SARS-CoV-2), displayed remarkable efficiency in combating coronavirus 19 (COVID-19).
mRNA vaccines train T cells in waves, study shows
- Post author:
- Post published:March 9, 2024
- Post category:uncategorized